OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology Europe
August 01, 2011
O-arylation and O-alkylation, a one-pot protein synthesis, a combined approach in continued and chemocatalysis, and green-chemistry applications are the target of some recent advances in API synthesis.
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.
The authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials.
The authors discuss the preparation of lipophilic drug nanocrystals by controlled crystallization during freeze-drying.
Visiting a new site or going down memory lane may not get you where you want to go.
While most companies recognise the significance of emerging markets, they struggle to jump the first hurdle in addressing these opportunities: defining the right product.
Is pharma failing in R&D?
Companies know they need regulatory information management, but they don't always know where to start and how to weave this capability across diverse technology applications.
Graham Rideal of Whitehouse Scientific explains the importance of filter testing and offers some considerations with regards to choosing filter test methods.
Marc Prieur of Aptar pharma describes success stories in emerging markets.
Croatia is on track to join the EU in 2013 and offers a well-developed pharmaceutical market. However, its EU membership application has undergone much scrutiny.
There have been several new stories and reports lately that paint a rather gloomy picture of the state of pharma R&D.
The challenge with any of the emerging markets is in adjusting to the western regulatory concepts of quality and compliance.